For the research, Which? conducted an online poll of 1,009 pet owners who had had an issue with their vet in the past two years.
It also conducted qualitative interviews with 14 owners who had complained.
The most common reasons for complaint were:
Of the 1009 pet owners who had experienced some kind of problem with their vet, 57% did NOT make a complaint, 33% because they did not want to fall out with their vet.
Pet owners who wish to complain about veterinary services have three options: to complain directly to their practice, to use the voluntary Vet Client Mediation Service (VCMS), or to raise a 'concern' with the RCVS.
The Which? report found that of those who did complain to their practice, 35% were not happy with the outcome and 31% with the way it was handled.
Which? found that although the VCMS reported a high resolution rate of 84% in 2022-23, its interviewees had found it a bit hit or miss.
Finally, Which? found the process of complaining to the regulator flawed by the fact that the threshold for the College to progress a 'concern' is set so high, because College has no jurisdiction at a practice level, and because it has no sanctions to use in enforcing consumer law.
The report recommends that:
Full report: https://www.which.co.uk/policy-and-insight/article/complaints-and-redress-in-veterinary-services-a5z611X9tZzf
CommentI loved the regal response from the RCVS to The Guardian about the case studies in the Which? report: “the facts presented in the case studies do not completely align with those reported to us”.
That aside, surely the big issue here is not so much that consumers have little way to complain effectively.
That is important, of course, but isn't it more important to consider what they are complaining about, which in the main is MONEY.
Driven by the advances in veterinary medicine, the innate desire of vets to provide the best possible care, anthropomorphising pet owners saying they want 'the best' for their fur baby (without necessarily having the wherewithal), corporatisation and society's changing expectations about working conditions, prices have been going up at a rate far outstripping inflation.
Increasing prices have of course been accompanied by an increase the standards of care and the range of clinical equipment.
But the question everyone must ask is at what point the cost of veterinary care for a dog outstrips the benefits of owning one?
These complaints are the canary in the coalmine.
Topics include applying the principles of antimicrobial stewardship (AMS), making confident diagnostic and prescribing decisions, and managing client expectations around antibiotic use within practice.
In the first episode, Tim explores how to apply the principles of AMS in the consulting room, starting with recognising when antibiotics are genuinely needed.
He explores the role of clinical signs and cytology in guiding diagnosis and treatment decisions, while also emphasising the risks of unnecessary prescribing.
The discussion also covers when empirical antibiotic use may be appropriate and how to ensure these decisions are justified.
Each episode offers practical, evidence-based insights which Krka says can be easily implemented in general practice.
The series is accompanied by downloadable Vet2Vet Insights information sheets that summarise the main take-home messages from each episode.
https://open.spotify.com/show/0uphORU03q29WncwmN2EIa
The information sheets are available here: https://www.krka.co.uk/veterinary-knowledge-hub/articles/responsible-use-of-companion-animal-antibiotics
The theme for the symposium this year is ‘Advancing veterinary mental health research: learning from the past, considering the present, and looking to the future’.
The day will consist of a variety of oral presentations and poster presentations, and there will be a number of exhibitors, including charitable organisations and wider animal health and welfare organisations.
The College is inviting all those interested in the field of veterinary mental health to attend the day.
RCVS Council member and Chair of the Mind Matters Initiative, Dr Louise Allum, said: “Our symposium presents a fantastic opportunity for knowledge exchange in the veterinary mental health sphere so that, together, we can continue to foster a compassionate environment and build a solid evidence-base for veterinary mental health research to grow and evolve.
“This is an inclusive event open to all with an interest in veterinary mental health including vets, nurses, students, practice managers, academics, healthcare professionals, policy makers, mental health advocates and everyone in between.”
MMI Lead Rapinder Newton added: “We have come a long way in developing our understanding of mental health in veterinary professionals over the past ten years but still have a way to go.
“Only through continued collaboration with mental health researchers, and learning from other allied professions, can we efficiently work towards our shared goal of enhancing mental health and support within the veterinary professions.
“This is why events such as our symposium are so important.
"Veterinary mental health is a small but growing field. Creating environments for open discussion and networking are key to advancing our understanding of where the challenges lie.
"By extension, this also plays an invaluable role in learning how research can be applied in a practical manner to help improve the lives of veterinary professionals which, ultimately, aids in upholding animal health and welfare too.”
https://www.eventbrite.co.uk/e/mind-matters-initiative-research-symposium-2025-tickets-1247144485729
Apparently the commonly reported use of AI technology was for radiography diagnostics and reporting (44%), followed by laboratory diagnostics and reporting (27%), communications with clients (11%) or to assist with administrative work (7%).
Vets were asked about the benefits and risks of using AI technology in their work.
The most common reported benefit was data interpretation (55%), followed by diagnostic testing (49%), saving time more generally (40%) and for routine admin tasks or note taking (38%).
The most commonly reported risks of AI were the possibility that results are interpreted without context (83%) or that AI is used incorrectly, without follow up checks (82%).
The other reported risks were an overreliance on AI undermining human skills (68%) and a lack of data protection (25%).
BVA Junior Vice President Rob Williams said: “It’s fascinating to see how many vet teams are already using AI technology in their daily work.
"The massive boom in the use of these tools represents an exciting opportunity for the profession, particularly around diagnostics and interpreting large data sets.
"But as well as benefits there are clear challenges and risks, so this timely session is a great opportunity to address some of the ethical questions around the use of technology when it comes to treating animals and ensuring their welfare.
"It’s set to be an interesting debate, with the chance for delegates to pose questions to our incredibly knowledgeable panel, and I hope many of you will join us to add your voice to the discussion.”
On the AI discussion panel at BVA Live will be: Nick Jackson, Director, Veterinary Surgeon, Council Member - NGJ Locum Ltd, Ben O'Halloran, Policy Officer - BVA and Nicolò Frisiani, Co-founder and CEO - Lupa Pets.
https://bvalive.vetshow.com/conference-programme
Photo: www.depositphotos.com
The six-floor building, which the College bought for £22.3m in 2022, was originally a warehouse.
Over the years it has been home to a range of businesses from leather manufacturers and papers makers to lithographic plate makers and shoe upping manufacturers, before becoming an office space.
The building remained tenanted until 2024, when £5.8m worth of renovation work to convert the building into a space suitable for a royal college began.
In addition to the working areas for RCVS and RCVS Knowledge staff, the building also has:
RCVS CEO, Lizzie Lockett, said: “After a few years in a rented co-working office space, we’re delighted to have moved into our new home, designed not only to meet the needs of College staff, but to support the broader ambitions of the RCVS as a whole.
“Our new strategic plan has collaboration at its heart – the idea of being stronger through working together – and our new building will help us to achieve that.
“Whether attending events, exploring RCVS Knowledge’s archives, using the members' area and meeting rooms, or benefitting from the outputs that the new space enables, the building has been developed with members and associates as a central focus.”
RCVS President, Linda Belton, added: "It’s great to see what’s been achieved through this project and my thanks go to the team who have managed the refurbishment and move.
“The new premises are equipped to ensure that the voice of the veterinary professions remains integral in assuring animal health, welfare, and public health in the UK, allowing for those all-important stakeholder conversations essential to setting, upholding and advancing veterinary standards.
“We look forward to welcoming members, associates, students and stakeholders alike in the coming months and years.”
The webinars cover a range of clinical topics, including evaluating Brachycephalic Obstructive Airway Syndrome (BOAS), cognitive decline in senior dogs, cannabinoid therapy, feline weight loss, corneal ulcers and seizure management.
Vet and Tech says the 10-session series features speakers from top veterinary institutions.
The webinars are available both both live and on-demand.
https://www.vetandtech.com/webinars
Mr Wood faced three charges, all relating to allegations of misconduct over a laboratory test for an alpaca while he was working at a practice in South Oxfordshire.
The charges alleged that in September 2023, Mr Wood told the alpaca’s owner that it had tested positive for Johne’s disease when in fact, the animal had not been tested.
He then allegedly sent a letter confirming a positive test result for the test that had not taken place, and then created a false test result report in the name of a veterinary surgeon colleague and sent it to another colleague by email.
He later told the alpaca's owner that he had given her the wrong result by mistake and that the test result was actually negative.
Then in October 2023, he emailed the laboratory saying that a member of his practice’s administrative staff had written the false report.
In November he told the managing partner of his then employer on three occasions that he was investigating the false report in order to find out who sent it.
Finally, he sent a misleading and dishonest email to a veterinary surgeon colleague falsely indicating that a member of the practice’s staff had manufactured the false report, when that was not the case.
At the outset of the hearing Mr Wood admitted the facts of all the allegations against him.
Having found the facts proven, the Committee found that the charges amounted to serious professional misconduct, something which Mr Wood himself also admitted.
The Committee identified a number of aggravating factors in Mr Woods' conduct, including his lack of honesty, probity and integrity, the fact the conduct was premeditated, that it involved a breach of the client’s trust, the abuse of his professional position, the fact the conduct was sustained and repeated over a period of time, and that his conduct contravened advice given by the RCVS.
The mitigating factors included positive testimonials from professional former colleagues and client farmers, the fact that he had engaged in some remediation in order to avoid repeating the dishonest behaviour, and that he showed significant insight into his misconduct.
Dr Neil Slater MRCVS, chairing the Committee and speaking on its behalf, said: “The Committee recognised that the serious repeated dishonesty, which was to conceal wrongdoing, made the respondent’s misconduct particularly serious.
“It therefore gave consideration as to whether his conduct was fundamentally incompatible with being a veterinary surgeon and whether removal was the only appropriate and proportionate sanction in this case.
“The Committee considered that this was a particularly difficult case to reconcile, as, on the one hand the misconduct was so serious whereas on the other hand, the respondent had demonstrated significant insight; the risk of repetition was low; the evidence of his professional achievements was strong and the testimonials from client farmers and professional colleagues were impressive.”
He added: “The Committee considers that suspension is sufficient in the circumstances of this case to satisfy public confidence in the profession and to uphold proper professional standards of conduct and behaviour.
"The Committee therefore imposes a suspension of 18 months on the respondent.
"In determining this length, the Committee considered that this was the least period necessary in order to meet the significant public interest considerations in this case.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings
Underlying the strategic plan are what the College says are its four updated values of compassion, collaboration, clarity and courage.
The plan lays out four strategic ambitions, each focused on one of its stakeholder groups, each one under the banner of 'Stronger Together'.
Veterinary professionals: "The RCVS will help veterinary professionals meet high standards and champion accessible, team-based veterinary care, delivered in settings that support professional autonomy and leadership."
This includes reviewing the Code of Professional Conduct and supporting guidance, achieving new veterinary legislation and ensuring that educational standards and career pathways meet the diverse needs of society.
Animal owners and keepers: "The RCVS will support animal health and welfare and public health by enabling access to veterinary care informed by the needs of consumers and service users."
This includes supporting and informing the public in how to get the best from veterinary professionals, with increased transparency, agency and choice.
Society at large: "The RCVS will champion the role that veterinary professionals play in One Health and public health, take a leadership role on environmental sustainability and biodiversity, and continue to look at how it can play a role in the global veterinary professions."
This includes leading the conversation on issues such as the cost of veterinary care, building enthusiasm for veterinary work in the minds of the next generation of potential professionals and ensuring veterinary professionals responsible for public health are well supported with robust standards and safeguards.
Staff team and governance: "The RCVS will attract and retain the diversity of talent and skills to deliver what’s needed now and anticipate what might be next and build a culture that allows people to thrive."
This includes developing an infrastructure for success, including the new RCVS headquarters, and underpinning structures for finance, communications and digital, creating a working culture with sound values and supportive management.
Lizzie Lockett, RCVS Chief Executive Officer, said: “The overall theme of the plan recognises that there are many other individuals and organisations that have a stake in our mission to inspire confidence in veterinary care and protect the public interest by ensuring animal health and welfare, and public health, are advanced through thriving world-class veterinary professions.
“This is where the ‘stronger together’ comes in, recognising that, in our role as a royal college that regulates, we are very well placed to bring people and organisations together to meet our common purpose of improved animal health and welfare and public health in a collaborative, proactive way.”
www.rcvs.org.uk/strategy25
From early 2025, all vets, nurses and technicians will be required to wear a hard hat in the vicinity of a horse, pony or donkey – whether in practice, on a yard, or at a client’s premises.
It follows a three-year research project collaborating with the University of Liverpool which revealed that 90% of veterinary clinicians have experienced an injury during their career.
It is hoped that the move will reduce injuries to the head – one of the most common traumas to be suffered by equine vets identified by the research, usually sustained when examining distal limbs. CVS says that in the US, equine vets sustain on average eight serious injuries during their career, making it the second highest profession for non-fatal injuries.
The University of Liverpool research found that over 25% of equine vet injuries have led to hospital attendance. Dr. John Tulloch, Lecturer and European Specialist in Veterinary Public Health at the University of Liverpool, who led the research, said: “Vet visits are not an ‘everyday activity’ for a horse.
"As a result, many horses will be on heightened alert, and some may be more prone to unpredictable behaviour. “Vets are often in a vulnerable situation when examining a horse.
"And it’s difficult to pick up on a horses’ signals, especially when examining areas such as distal limbs. “Our research found that many injuries happen when a horse kicks or pushes a person over and the person’s head makes impact with the ground.
"So, wearing a hard hat will be a big step towards preventing traumatic head injuries if this were to happen.” Sophie Ignarski, Equine Director at CVS said: “All of our clinicians are at risk in their day-to-day work – whether they are newly qualified or very experienced.
"Other colleagues including nurses, vet techs and patient care assistants are similarly vulnerable. “We decided to make wearing of hard hats mandatory in order to protect all of our colleagues and minimise the potential risk of head injury, understanding it can never be fully eliminated.
"We recognise that this policy shift represents a degree of change but hope that it serves to further support and progress the equine veterinary industry more widely. “Our policy is evidence-based, utilising three years of rigorous research, and we will continue our efforts in the future to grow our knowledge and understanding of this important area.
"By doing so, we join other industries – such as construction – who have already adopted similar changes to the extent they are now established in their culture.”
https://www.sciencedirect.com/science/article/pii/S0167587725001266
The range will include Vetoryl 20mg, 30mg and 60mg hydrolysed chicken flavoured tablets, which can be broken into halves or quarters.
The new Vetoryl tablets will come in packs of 30 tablets, although no word from Dechra as to when they'll arrive.
Thomas Johnson, Vetoryl brand manager at Dechra, said: “We are delighted that Vetoryl Flavoured Tablets for Dogs will soon be available, which will provide vets and pets owners with easy to administer, flavoured tablets to provide additional dosing flexibility.
"This, together with our commitment to providing extensive technical support and resources, will ensure that Vetoryl continues to be the UK’s leading licensed medical treatment for Cushing’s syndrome.”
ESCCAP says that the risk of novel parasites and zoonoses spreading to new regions has risen alongside an increase in pet travel and changing climate conditions.
ESCCAP’s Guideline 09 offers detailed advice on how to protect dogs and cats that travel or are imported across European borders, minimise the risk of zoonotic transmission and prevent the establishment of new parasites in previously unaffected areas.
Topics covered in the guideline include:
The guideline emphasises the importance of early detection of parasitic infections by thorough clinical examinations, comprehensive travel history assessments and targeted diagnostic testing.
It also provides guidance on educating pet owners about zoonotic risks and implementing appropriate treatments and follow-up screenings.
www.esccap.org/guidelines/gl9/
Vet-AI's automated triage app offers instant advice to pet owners 24/7, early detection of health issues and advice as to whether they need to speak to a vet.
For the blinded test, which was conducted in April 2025, three UK veterinary surgeons reviewed the responses from Vet-AI, Gemini 2.0 and ChatGPT 4.0 to 48 simulated enquiries from owners.
The vets evaluated each on clinical accuracy, triage effectiveness and the subjective criteria of factuality, integrity, safety, empathy and readability.
Vet-AI’s Large Language Model (LLM) achieved an accuracy score of 81%, surpassing Gemini (69%) and ChatGPT (50%).
Vet-AI’s model also stopped triage at the correct point in 81% of cases according to the vets, compared with Gemini’s 75% and ChatGPT’s 56%.
Vet-AI’s tool also outperformed the leading LLMs on subjective measures, delivering more empathetic, thorough and factual responses to pet owners.
Samantha Webster, Chief Veterinary Officer at Vet-AI said: “These latest results are a significant milestone in the development of automated triage.
"We’re proving we can provide trustworthy online pet care by combining clinical and technical expertise.
"This tool can support the wider industry too, engaging more pet owners in the first step of vet care, ensuring their pets get the care they need - whether in practice or remotely.
"We know that an increasing percentage of the UK pet population is struggling to access veterinary care.
"Whilst AI will never replace a vet, the use of innovative technology can break down the barrier to access, leading to more pets getting the care they need, when they need it."
“With this level of clinical accuracy and technical innovation, we're helping to bring great pet care to more people. As well as helping to create more demand for vet services by making the triage of pets as accurate as possible,” said Paul Hallett, Vet-AI founder and exec chair.
https://www.vet-ai.com/automated-triage
Presented by The Webinar Vet and Vet Dynamics, the Vet Trust Awards celebrate notable contributions to veterinary advancement.
Claire Towers, General Manager of Hill’s Pet Nutrition UK and Ireland said: “Our recognition as the most trusted pet food brand is a testament to the unwavering dedication of the Hill’s team, ensuring vets remain integral to our mission.”
The March 2025 Cattle Highlights Report from the Royal GD in the Netherlands has revealed that the proportion of paromomycin-resistant isolates has jumped from 48% in 2021 to 72% in 2024.
The report also highlights an increase in the detection of cryptosporidiosis in calves up to 14 days of age.
MSD says that while it is unclear whether paromomycin is being used to treat E.coli or cryptosporidiosis, the rising use of the antibiotic could be contributing to greater exposure and increased resistance in E.coli K99.
Kat Baxter-Smith MRCVS (pictured), a vet advisor at MSD Animal Health, said: “What we need now is a mindset shift—moving away from routine antibiotic use and towards a more robust, preventative management strategy.
“It’s not about eliminating treatment altogether but using it only when it is really needed.”
“Vaccination, clean pens, and ensuring that every calf receives the right volume and quality of colostrum are the real cornerstones of effective scour control.
“Using vaccines such as Bovilis Rotavec Corona for rotavirus, coronavirus, and E.coli and Bovilis Cryptium for Cryptosporidium parvum is one of the most effective ways to reduce the incidence of neonatal diarrhoea.
"By vaccinating the dam, we ensure the calf has the best possible immunity at birth by ingesting the fortified colostrum and transition milk in the first days of life, which significantly reduces reliance on antibiotics and minimises disease risks.”
The report emphasises best-practice principles such as effective colostrum management, good hygiene and housing, balanced dry cow transition and strategic vaccination of the dam.
The report also recommends halofuginone (Halocur) as the first-line treatment for cryptosporidiosis, due to its targeted action and significantly lower risk of contributing to AMR.
Kat added: "By embracing these proactive strategies, vets and farmers can take a crucial step towards safeguarding calf health, reducing reliance on antibiotics, and combating the growing threat of antimicrobial resistance.”
https://issuu.com/gezondheidsdienstvoordieren/docs/highlights_report_cattle-march_2025
The factsheets, which cover canine chronic bronchitis, feline asthma and equine asthma, are designed to help explain complex conditions more effectively, encourage earlier diagnosis, and improve treatment compliance.
The downloadable factsheets can be printed, emailed to clients, or displayed in waiting areas and on waiting room screens.
Jon Slattery MRCVS, Director of BreathEazy, said: “We often see a seasonal spike in respiratory cases at this time of year, particularly in animals with underlying conditions.
"Having owners on board and confident in managing their pet’s condition is a key part of treatment success.
"These factsheets offer a time-saving way for vets and nurses to educate clients, reinforce advice given in consults, and help owners understand how to support their pets at home.”
https://mailchi.mp/breatheazy/resourcedownload
www.breatheazy.co.uk
The guide is aimed at established practices, new start-ups and those who may be thinking about setting up a practice.
It includes practical information, videos and first hand advice from independent practice leaders who are members of Vetsure and who've successfully navigated the challenges of practice ownership and management.
In the book, Diane Storer of Cockburn Vets offers tips for recruiting and building a collaborative team, whilst Julie Hutton of Hilltop Vets shares her thoughts on leadership and addressing practice challenges.
Other contributors to the guide include Vicki Farbon of Scott Veterinary Clinic, Kate Hornby of Wild Side Vets, Emily Nightingale of Nightingale Vets and Simon Hayes of Creature Comforts, who draw from their diverse experiences of founding and operating independent practices.
Ashley Gray, Managing Director of Vetsure said: “The insights from successful independent practice owners and Vetsure network members included in the guide offer lessons from real experiences beyond generic business courses."
He added: “The Vetsure network aims to support and champion independent veterinary practices by sharing knowledge and expertise, facilitating learning from fresh perspectives and ideas, and fostering genuine collaboration,”
https://www.vetsurevet.com/guide-to-success
To mark the end of his presidential year at BSAVA, Julian will be strapped to the top of a vintage biplane while dressed in a full feline (Cheshire Cat) costume, to support the research that BSAVA PetSavers funds to improve the health and wellbeing of pets across the UK.
BSAVA PetSavers is one of the UK’s few funding bodies focused solely on clinical research into diseases affecting companion animals.
To date, it has invested more than £2.7 million in vital studies addressing conditions such as cancer, heart disease, neurological and joint disorders, gastrointestinal issues.
Julian said: "Every day, vets face the heart-wrenching task of managing the distress and pain our pets suffer due to disease or poor health.
"With your support, we can ensure that they have access to the latest knowledge and resources needed to provide the best care possible.
“The need for advanced research is more pressing than ever and our pets deserve every chance at a healthy life.
"If dressing up as a cat and flying on the wing of a plane makes people take notice of the vital need for pet health research, then it will be worth it.”
Alison Selby, Fundraising Manager for BSAVA PetSavers said: “No one has ever been quite so daring in their fundraising efforts for us, so we are thrilled that Julian has decided to take this on to raise awareness and funds for BSAVA PetSavers.
“For every grant application that we fund, at least two or more are declined due to lack of funds. Fundraising events like this helps to land more funding in the hands of researchers who make a real difference in the veterinary community and directly impact the lives of countless pets and their families.”
Julian’s wing walk is on the 29th May and his target is to fundraise £1,000.
https://www.justgiving.com/page/julian-hoad-2
The company says the webinar, presented by Dechra veterinary technical advisor, Emily Casey BVM&S MRCVS (pictured), will save vets' time and enhance their canine patients’ quality of life.
Emily said: “Canine Cushing’s syndrome can seem over-complicated, and we receive about 200 calls a month on the disease, so we’ve seen it all.
"Our new webinar will provide vets with a straightforward, no-nonsense approach to Cushing’s that will transform how they manage their next canine Cushing’s case.”
Delegates who join the webinar live will be entered into a prize draw to win a Littman Classic III Stethoscope.
https://go.dechra.co.uk/3-things-about-cushings
Super early bird tickets are available till 28th May.
Rose’s programme recommendations are:
BEVA Congress programme will be embracing the overarching theme of “use it wisely or lose it forever”, chosen by BEVA President Bruce Bladon.
Bruce said: “Antibiotics is an issue which goes so far beyond equine practice and is one of the genuine threats to humanity.
"We must use these precious and finite resource wisely, or, quite reasonably, regulators will prevent us having access to them.
“But this theme resonates further, to the “social licence” which threatens the future of equine sport.
"Rather than platitudes about horse welfare, we now need to show the positive steps we can take to minimise equine injury.
"We need to be developing screening programmes and to be instrumental in safety programmes.
"Otherwise, we may lose equestrian sport forever.”
Individual super early bird BEVA members prices for a three-day pass are £539 for vets for all three days (with concessionary available for those in their first three years of graduation or earning less than £25,000).
Day tickets and practice passes are also available.
Super early bird ends on 28 May 2025.
http://www.bevacongress.org
The map gives an overview of the regulation applying to virtual care in different countries and it shows how virtual veterinary care is regulated predominantly in Western European countries only.
For the countries where veterinary virtual care is subject to regulation, the new map shows which countries:
https://vvca.org/resources/europe
Conducted as a multicentric international study involving board-certified veterinary dermatologists, the trial included 35 dogs with CIF in at least two paws.
Each dog acted as its own control, and was treated with systemic antibiotics, with one paw being treated with FLE and the other paw without.
Paws were allocated based on a coin toss, and the study was single blinded: the principal investigator was responsible for the assessment of lesions, and the co-investigator was responsible for administration of FLE treatment.
The dogs were assessed over an 8-week period with check-ups every 14 days.
At every check-up the paws treated with FLE showed a greater improvement than paws without FLE treatment.
The lesions were assessed and scored with the global lesion score, the pruritic visual analogue scale, a cytological scoring, and photographic documentation.
The results of the study demonstrated that FLE combined with systemic antibiotics significantly reduced the time to clinical resolution compared to antibiotics alone.
By week four, 50% of paws in the FLE group had reached clinical resolution compared to 17% in the control group.
By week eight, 88% of paws in the FLE group had healed compared to 54% in the control group.
Dr Anja Lange, DVM, Department of Dermatology, AniCura Kleintierspezialisten Augsburg GmbH, Augsburg, Germany, said: “Canine interdigital furunculosis is a challenging condition to treat that can be prolonged and frustrating.
"Having FLE as an additional management tool is very exciting, not least because it speeds up time to healing, but it also requires us to use less antibiotics.
"The use of FLE was well accepted by all of the dog owners from the study and the dogs themselves tolerated it well, showing it can be a very useful adjunct to cases in clinical practice.”
Reference
The award, which is sponsored by Zoetis, celebrates vets in the first eight years of their career who have shown outstanding care, dedication or success.
Nominees may have delivered exceptional care to a patient, made a positive contribution to their community or the wider veterinary profession, or shown their dedication to a cause.
Early career vets who are keen to demonstrate their ambition and dedication to the profession can also self-nominate for the award.
British Veterinary Association President Elizabeth Mullineaux said: “We know how hard all vets work to care for the UK’s animals and to protect both human and animal health and welfare.
"Our young and early career vets deserve to have their incredible work recognised and this award is an opportunity to highlight their compassion, skills and positive contribution to the profession.”
The winner will be announced on Thursday 16th October 2025 at the BVA Awards in London, where they will be awarded a prize package which includes £1,000, a year of free BVA membership and mentoring/engagement opportunity with Zoetis.
The deadline for entries is 9am on Monday 4th August 2025.
www.bva.co.uk/YVOTY
Photo: Last year's winner, David Charles.
The study is being conducted with pet owners and veterinary professionals to develop a greater understanding about how flea and tick treatments are used on cats and dogs.
It will involve two depth surveys to explore the type and format of treatments used, the frequency of application, where treatments are bought, what influences the choice of product, whether there is an awareness of ectoparasiticides’ environmental effect and what preventative steps the public and clinicians would take when using the treatments on animals in the future.
At a later stage, the research project will also include lab assessments of ectoparasiticide residues collected from companion animals to provide more information on their potential environmental impact.
It is hoped the research findings will help the veterinary profession develop the most appropriate approaches to ectoparasiticides in the future, and inform educational strategies to support owners with ‘responsible use’.
Project leader Professor Richard Wall from the University of Bristol, said: “This is an issue of considerable concern.
"Citizen science and laboratory research evidence is urgently needed so that risk-based assessments of the impact of and requirements for ectoparasite treatment can be made.
"Whilst we can make some assumptions around the impact of routine ectoparasite treatments, these findings are essential for us to truly understand them - and to be able to balance the needs of veterinary patients with their wider environmental impacts.”
https://forms.office.com/e/mbztbYf4Ru.
The Health Products Regulatory Authority (HPRA) has also granted a marketing authorisation in exceptional circumstances (Article 25, 26 EU Reg 2019/6) for Bultavo 3 in Ireland.
The company says that so far, more than 40 million doses of Bultavo 3 have been distributed in Europe to help limit the spread of BTV-3.
Boehringer points to a recent field study published by the German reference laboratory Friedrich-Loeffler-Institut (FLI), which showed that vaccination of sheep and cattle with Bultavo 3 induces immunity against the virus1.
According to the study, animals vaccinated with Bultavo 3 consistently showed evidence of a protective antibody response to BTV-3, although animals vaccinated with other BTV-3 vaccines did not1.
Boehringer says it is now compiling the data needed to obtain a full marketing authorisation in accordance with Article 8 of EU Regulation 2019/6.
Bravecto Triuno is approved for the treatment of tick and flea infestations in dogs (Ctenocephalides felis, C. canis, Dermacentor reticulatus, Ixodes hexagonus, Ixodes ricinus, and Rhipicephalus sanguineus).
It is also approved for the treatment of infections with roundworms (adult stages of Toxocara canis and Toxascaris leonina) and hookworms (L4, immature adult (L5), and adult stages of Ancylostoma caninum and Uncinaria stenocephala), for the prevention of heartworm disease (caused by Dirofilaria immitis), and for the prevention of angiostrongylosis (by reduction of the level of infection with immature adult (L5) and adult stages of Angiostrongylus vasorum).
Victoria Miles, UK Companion Animal Director, MSD Animal Health, said: “With this latest formulation of Bravecto, MSD Animal Health is giving veterinarians and dog owners a greater range of convenient options for protecting their dog year-round from parasites, and all from the same trusted Bravecto portfolio.”
She added: “We see Bravecto Triuno as a great option for puppies that require a monthly wormer on top of protection against fleas and ticks.
"This also gives flexibility later on for the dog to remain with the Bravecto brand but be swapped onto a longer-duration flea and tick product with a wormer administered according to a veterinarian’s risk-based assessment.”
Bravecto Triuno is available as a flavoured chewable tablet indicated for dogs and puppies from 8 weeks of age and at least 1.27 Kg body weight and can be administered monthly to dogs at risk of infestation by multiple types of internal and external parasites.
It contains three anti-parasitic ingredients including fluralaner, which provides activity against ticks and fleas, moxidectin, which provides systemic activity against non-intestinal worms, and pyrantel, which provides activity against intestinal worms.
https://www.noahcompendium.co.uk/?id=-488423